ECPs’ approach to dry eye management

The TFOS DEWS II reports were published in 2017, bringing practitioners up to date on the scientific evidence related to dry eye disease (DED), including...

Tackling the DED vicious circle

A recently awarded Health Research Council (HRC) project grant will investigate a novel eye drop that tackles the vicious circle of dry eye disease (DED),...

Artificial tears: preserved or non-preserved, that is the question

With apologies to William Shakespeare for the title, this was indeed the question addressed in our recent literature review1. With increasing availability...

Castor oil for blepharitis

Blepharitis is one of the most common ophthalmic conditions, characterised by chronic inflammation of the eyelid tissues and affecting the eyelashes, meibomian...

Amniotic membrane for DED

Dry eye disease is a common ocular surface disorder, resulting in one of the most frequently encountered complaints in ophthalmic practice. Whilst the...

Oculoplastics research update

Success of endoscopic dacryocystorhinostomy with or without stents Maria Julia Orsolini, Silvana Artioli Schellini, Roberta Lilian Fernandes Souza Meneguim &...

Worrying results from Welcome to School study

Uncorrected refractive errors account for up to 96% of visual impairment in school-aged children and are associated with amblyopia and strabismus development,...

Cornea research update

CXL-assisted infection reduction: a randomised clinical trial evaluating the effect of adjuvant CXL on outcomes in fungal keratitis

Strabismus update

Three-year observation of children, aged three to 10 with untreated intermittent exotropiaPediatric Eye Disease Investigator Group, Cotter SA et al. Ophthalmology...

OTC 2020: the good, the bad and the future therapeutics

The 2020 Ocular Therapeutics Conference (OTC) lived up to its name, providing interesting advice and discussion about new and old therapeutics for common...

Diabetic macular oedema, AMD and more

Effect of initial management with aflibercept vs laser photocoagulation vs observation on vision loss among patients with diabetic macular oedema: a randomised...

CASE STUDY: Optimising outcome in non-exudative AMD

A 68-year-old man has been under my care for age-related macular degeneration (AMD). His right eye is under long-term anti-VEGF therapy for wet AMD. He...

43 articles found

Bottom Banner Advert